Panaxia Labs Israel Ltd
TASE:PNAX
Fundamental Analysis

Revenue & Expenses Breakdown
Panaxia Labs Israel Ltd
Balance Sheet Decomposition
Panaxia Labs Israel Ltd
Current Assets | 17.4m |
Cash & Short-Term Investments | 903k |
Receivables | 5.4m |
Other Current Assets | 11m |
Non-Current Assets | 4.6m |
PP&E | 2.3m |
Intangibles | 131k |
Other Non-Current Assets | 2.2m |
Free Cash Flow Analysis
Panaxia Labs Israel Ltd
ILS | |
Free Cash Flow | ILS |
Earnings Waterfall
Panaxia Labs Israel Ltd
Revenue
|
26.4m
ILS
|
Cost of Revenue
|
-46.7m
ILS
|
Gross Profit
|
-20.3m
ILS
|
Operating Expenses
|
-8.5m
ILS
|
Operating Income
|
-28.8m
ILS
|
Other Expenses
|
-1.5m
ILS
|
Net Income
|
-30.3m
ILS
|
PNAX Profitability Score
Profitability Due Diligence
Panaxia Labs Israel Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Panaxia Labs Israel Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
PNAX Solvency Score
Solvency Due Diligence
Panaxia Labs Israel Ltd's solvency score is 20/100. The higher the solvency score, the more solvent the company is.
Score
Panaxia Labs Israel Ltd's solvency score is 20/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PNAX Price Targets Summary
Panaxia Labs Israel Ltd
Dividends
Current shareholder yield for PNAX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?